1. Discontinuation of empirical antibiotic therapy in neutropenic acute myeloid leukaemia patients with fever of unknown origin: is it ethical?. (9th December 2013) Authors: Micol, J.‐B.; Chahine, C.; Woerther, P.‐L.; Ghez, D.; Netzer, F.; Dufour, C.; Merad, M.; Blot, F.; Chachaty, E.; de Botton, S.; Gachot, B.; Grobusch, M. Journal: Clinical microbiology and infection Issue: Volume 20:Number 7(2014:Jul.) Page Start: O453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1249: Repeated low-dose radiation therapy in indolent Non-Hodgkin Lymphoma patients. (April 2018) Authors: Saleh, K.; Michot, J.M.; Schernberg, A.; Danu, A.; Lazarovici, J.; Ghez, D.; Girinsky, T.; Khalife-Saleh, N.; Mazeron, R.; Ribrag, V.; Boros, A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FEASIBILITY AND BENEFIT OF MOLECULARLY‐INFORMED ENROLLMENT INTO EARLY PHASE CLINICAL TRIALS FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) Authors: Michot, J.; Camara‐Clayette, V.; Detolle, A.; Chahine, C.; Lazarovici, J.; Danu, A.; Bosq, J.; Ghez, D.; Romano‐Martin, P.; Dartigues, P.; Arfi‐Rouche, J.; Bahleda, R.; Rahali, W.; Varga, A.; Baldini, C.; Tselikas, L.; Paume, C.; Lecourt, H.; Cotteret, S.; Vergé, V. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Molecular landscape of relapse/refractory diffuse large B‐cell lymphoma. (June 2017) Authors: Michot, J.; Camara‐Clayette, V.; Chahine, C.; Lazarovici, J.; Bosq, J.; Ghez, D.; Dartigues, P.; Danu, A.; Arfi‐Rouche, J.; Tselikas, L.; Ba, B.; Cotteret, S.; Rahali, W.; Vergé, V.; Ribrag, V. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PV-0044: Is involved-node radiotherapy for Hodgkin lymphoma safe in routine?. (May 2017) Authors: Boros, A.; Sun, R.; Arfi Rouche, J.; Lazarovici, J.; Ghez, D.; Michot, J.M.; Beaudré, A.; Danu, A.; Bosq, J.; Ribrag, V.; Mazeron, R. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease. (April 2017) Authors: Annereau, M.; Willekens, C.; El Halabi, L.; Chahine, C.; Saada, V.; Auger, N.; Danu, A.; Bermudez, E.; Lazarovici, J.; Ghez, D.; Leary, A.; Pistilli, B.; Lemare, F.; Solary, E.; de Botton, S.; Desmaris, R.-P.; Micol, J.-B. Journal: Leukemia research Issue: Volume 55(2017:Apr.) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗